Synthetic biology promises to address many of the world’s biggest challenges in health and sustainability. At the core of the industry is custom-made DNA, and the demand for DNA synthesis is surging. However, the most widely used DNA synthesis technology—chemical oligonucleotide synthesis—can't synthesize gene-length sequences directly. Instead, longer sequences are stitched together from many shorter strands using a process that is failure-prone and struggles on many important types of sequences. As the synbio industry advances, new methods for reliable synthesis of longer DNA constructs without sequence limitations are needed to drive the next wave of innovation. Join this talk to understand the paradigm shift from chemical to enzymatic oligonucleotide synthesis and learn how to leverage this new era of fast, reliable access to long synthetic DNA to accelerate your research.